LAM-话题@MedSci

#LAM#

157篇内容 | 3998人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2057578, encodeId=8954205e5785a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：正念疗法可作为炎症性肠炎患者的有效干预措施, objectType=article, longId=58439, objectId=9e1258439e3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9e1258439e3, replyNumber=0, likeNumber=86, createdTime=2016-02-09, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9e1258439e3, moduleTitle=Inflamm Bowel Dis：正念疗法可作为炎症性肠炎患者的有效干预措施, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9e1258439e3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057574, encodeId=ea41205e57495, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=J Neuroinflammation：Met-CCL5能延长狂犬病患者生存, objectType=article, longId=40880, objectId=6581408802f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6581408802f, replyNumber=0, likeNumber=66, createdTime=2015-01-15, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6581408802f, moduleTitle=J Neuroinflammation：Met-CCL5能延长狂犬病患者生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6581408802f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057577, encodeId=08ed205e57761, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：儿时家暴及性暴力，成年溃疡性结肠炎患病率增加, objectType=article, longId=54635, objectId=c8d554635de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8d554635de, replyNumber=0, likeNumber=79, createdTime=2016-03-01, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8d554635de, moduleTitle=Inflamm Bowel Dis：儿时家暴及性暴力，成年溃疡性结肠炎患病率增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8d554635de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057572, encodeId=ed7e205e5729a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=ERJ：联合应用LABA/LAMA治疗中-重度COPD优于单药治疗, objectType=article, longId=28916, objectId=322028916b4, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=322028916b4, replyNumber=0, likeNumber=75, createdTime=2014-11-25, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=322028916b4, moduleTitle=ERJ：联合应用LABA/LAMA治疗中-重度COPD优于单药治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=322028916b4)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057571, encodeId=cdfe205e571f8, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=默沙东旗下黑色素瘤药物Lambrolizumab显著增加患者生存期, objectType=article, longId=26919, objectId=39d7269196b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=39d7269196b, replyNumber=0, likeNumber=74, createdTime=2014-01-17, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=39d7269196b, moduleTitle=默沙东旗下黑色素瘤药物Lambrolizumab显著增加患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=39d7269196b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057573, encodeId=550a205e57369, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=EASL 2014：聚乙二醇干扰素LAMBDA 早期抗HBV疗效优于ALFA, objectType=article, longId=33348, objectId=4bae3334873, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4bae3334873, replyNumber=0, likeNumber=66, createdTime=2014-06-21, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4bae3334873, moduleTitle=EASL 2014：聚乙二醇干扰素LAMBDA 早期抗HBV疗效优于ALFA, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4bae3334873)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057569, encodeId=383b205e5696e, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=欧洲药管局否决Delamanid上市许可, objectType=article, longId=23424, objectId=a3c523424ef, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3c523424ef, replyNumber=0, likeNumber=70, createdTime=2014-02-05, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3c523424ef, moduleTitle=欧洲药管局否决Delamanid上市许可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3c523424ef)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057568, encodeId=9208205e5687a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：武汉炎性肠病(IBD)的流行病学调查, objectType=article, longId=23294, objectId=e4c12329454, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4c12329454, replyNumber=0, likeNumber=58, createdTime=2014-01-16, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4c12329454, moduleTitle=Inflamm Bowel Dis：武汉炎性肠病(IBD)的流行病学调查, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4c12329454)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057567, encodeId=ca28205e5677a, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=FDA授予Alnylam RNAi药物ALN-AT3孤儿药地位, objectType=article, longId=23241, objectId=b5832324158, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b5832324158, replyNumber=0, likeNumber=68, createdTime=2013-09-07, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b5832324158, moduleTitle=FDA授予Alnylam RNAi药物ALN-AT3孤儿药地位, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b5832324158)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057565, encodeId=48ee205e56534, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=J Neuroinflammation：阻断过度活化受体恢复阿尔茨海默氏症小鼠记忆功能, objectType=article, longId=20349, objectId=05cd203498b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05cd203498b, replyNumber=0, likeNumber=76, createdTime=2014-04-02, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05cd203498b, moduleTitle=J Neuroinflammation：阻断过度活化受体恢复阿尔茨海默氏症小鼠记忆功能, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05cd203498b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057564, encodeId=1174205e56402, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：甲氨蝶呤联合激素治疗溃疡性结肠炎有助于缓解后激素的撤药, objectType=article, longId=20245, objectId=182c20245fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=182c20245fa, replyNumber=0, likeNumber=75, createdTime=2014-01-05, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=182c20245fa, moduleTitle=Inflamm Bowel Dis：甲氨蝶呤联合激素治疗溃疡性结肠炎有助于缓解后激素的撤药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=182c20245fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057562, encodeId=685e205e56228, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=默沙东黑色素瘤药物Lambrolizumab获FDA“突破性疗法”资格, objectType=article, longId=17779, objectId=3c3a1e77906, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c3a1e77906, replyNumber=0, likeNumber=82, createdTime=2013-10-28, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c3a1e77906, moduleTitle=默沙东黑色素瘤药物Lambrolizumab获FDA“突破性疗法”资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c3a1e77906)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057570, encodeId=d7b9205e570a5, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Alnylam RNAi 胆固醇药物一期实验结果良好, objectType=article, longId=25334, objectId=9b6425334b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6425334b7, replyNumber=0, likeNumber=57, createdTime=2013-10-18, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6425334b7, moduleTitle=Alnylam RNAi 胆固醇药物一期实验结果良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b6425334b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057563, encodeId=5780205e5635d, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=JID：LAMP试剂盒诊断疟疾快速准确, objectType=article, longId=19036, objectId=ba3219036ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba3219036ab, replyNumber=0, likeNumber=78, createdTime=2013-08-08, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba3219036ab, moduleTitle=JID：LAMP试剂盒诊断疟疾快速准确, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ba3219036ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057566, encodeId=7514205e5668f, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=Inflamm Bowel Dis：IBD患者发生淋巴瘤的危险因素, objectType=article, longId=20387, objectId=40f32038e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=40f32038e5a, replyNumber=0, likeNumber=78, createdTime=2013-11-04, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=40f32038e5a, moduleTitle=Inflamm Bowel Dis：IBD患者发生淋巴瘤的危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=40f32038e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057561, encodeId=75d8205e56190, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=INFLAMM BOWEL DIS：中国儿童炎症性肠病报告, objectType=article, longId=15618, objectId=d7e6156187f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7e6156187f, replyNumber=0, likeNumber=87, createdTime=2013-03-31, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7e6156187f, moduleTitle=INFLAMM BOWEL DIS：中国儿童炎症性肠病报告, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d7e6156187f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2057560, encodeId=9cd6205e56033, content=<a href='/topic/show?id=c02b106e29a' target=_blank style='color:#2F92EE;'>#LAM#</a>, objectTitle=NEJM：Delamanid可增强耐药结核的疗效, objectType=article, longId=6981, objectId=951e69815a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=951e69815a, replyNumber=0, likeNumber=90, createdTime=2013-04-21, rootId=0, userName=lxg951, userId=04ce158, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=951e69815a, moduleTitle=NEJM：Delamanid可增强耐药结核的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=951e69815a)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

LAM

2020-05-29

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：正念疗法可作为炎症性肠炎患者的有效干预措施

2016-02-09

lxg951 (审核中...)

前往app查看评论内容

#LAM#

J Neuroinflammation：Met-CCL5能延长狂犬病患者生存

2015-01-15

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：儿时家暴及性暴力，成年溃疡性结肠炎患病率增加

2016-03-01

lxg951 (审核中...)

前往app查看评论内容

#LAM#

ERJ：联合应用LABA/LAMA治疗中-重度COPD优于单药治疗

2014-11-25

lxg951 (审核中...)

前往app查看评论内容

#LAM#

默沙东旗下黑色素瘤药物Lambrolizumab显著增加患者生存期

2014-01-17

lxg951 (审核中...)

前往app查看评论内容

#LAM#

EASL 2014：聚乙二醇干扰素LAMBDA 早期抗HBV疗效优于ALFA

2014-06-21

lxg951 (审核中...)

前往app查看评论内容

#LAM#

欧洲药管局否决Delamanid上市许可

2014-02-05

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：武汉炎性肠病(IBD)的流行病学调查

2014-01-16

lxg951 (审核中...)

前往app查看评论内容

#LAM#

FDA授予Alnylam RNAi药物ALN-AT3孤儿药地位

2013-09-07

lxg951 (审核中...)

前往app查看评论内容

#LAM#

J Neuroinflammation：阻断过度活化受体恢复阿尔茨海默氏症小鼠记忆功能

2014-04-02

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：甲氨蝶呤联合激素治疗溃疡性结肠炎有助于缓解后激素的撤药

2014-01-05

lxg951 (审核中...)

前往app查看评论内容

#LAM#

默沙东黑色素瘤药物Lambrolizumab获FDA“突破性疗法”资格

2013-10-28

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Alnylam RNAi 胆固醇药物一期实验结果良好

2013-10-18

lxg951 (审核中...)

前往app查看评论内容

#LAM#

JID：LAMP试剂盒诊断疟疾快速准确

2013-08-08

lxg951 (审核中...)

前往app查看评论内容

#LAM#

Inflamm Bowel Dis：IBD患者发生淋巴瘤的危险因素

2013-11-04

lxg951 (审核中...)

前往app查看评论内容

#LAM#

INFLAMM BOWEL DIS：中国儿童炎症性肠病报告

2013-03-31

lxg951 (审核中...)

前往app查看评论内容

#LAM#

NEJM：Delamanid可增强耐药结核的疗效

2013-04-21

科室
- - 订阅+
  - 更多科室
工具
服务